These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 10331548

  • 1. In vivo properties of three human HER2/neu-expressing murine cell lines in immunocompetent mice.
    Penichet ML, Challita PM, Shin SU, Sampogna SL, Rosenblatt JD, Morrison SL.
    Lab Anim Sci; 1999 Apr; 49(2):179-88. PubMed ID: 10331548
    [Abstract] [Full Text] [Related]

  • 2. Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice.
    Wei H, Wang S, Zhang D, Hou S, Qian W, Li B, Guo H, Kou G, He J, Wang H, Guo Y.
    Clin Cancer Res; 2009 Jul 15; 15(14):4612-21. PubMed ID: 19584156
    [Abstract] [Full Text] [Related]

  • 3. DNA vaccination against neu reduces breast cancer incidence and metastasis in mice.
    Lachman LB, Rao XM, Kremer RH, Ozpolat B, Kiriakova G, Price JE.
    Cancer Gene Ther; 2001 Apr 15; 8(4):259-68. PubMed ID: 11393278
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Cytolysis of tumor cells expressing the Neu/erbB-2, erbB-3, and erbB-4 receptors by genetically targeted naive T lymphocytes.
    Altenschmidt U, Kahl R, Moritz D, Schnierle BS, Gerstmayer B, Wels W, Groner B.
    Clin Cancer Res; 1996 Jun 15; 2(6):1001-8. PubMed ID: 9816261
    [Abstract] [Full Text] [Related]

  • 8. Anti-tumor immunity induced by an anti-idiotype antibody mimicking human Her-2/neu.
    Mohanty K, Saha A, Pal S, Mallick P, Chatterjee SK, Foon KA, Bhattacharya-Chatterjee M.
    Breast Cancer Res Treat; 2007 Jul 15; 104(1):1-11. PubMed ID: 17004107
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. A single low dose of dendritic cells modified with lentivirus containing a truncated neu gene can effectively suppress neu-overexpressing tumors.
    Li GB, Lu GX.
    J Gene Med; 2010 Jul 15; 12(7):604-12. PubMed ID: 20533530
    [Abstract] [Full Text] [Related]

  • 17. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
    Cabodi S, Tinnirello A, Di Stefano P, Bisarò B, Ambrosino E, Castellano I, Sapino A, Arisio R, Cavallo F, Forni G, Glukhova M, Silengo L, Altruda F, Turco E, Tarone G, Defilippi P.
    Cancer Res; 2006 May 01; 66(9):4672-80. PubMed ID: 16651418
    [Abstract] [Full Text] [Related]

  • 18. [Down regulation of HER2/neu expression by adenovirus E1A and its anti-tumor activity].
    Lu H, Qin H, Zhang Y.
    Zhonghua Zhong Liu Za Zhi; 2000 Sep 01; 22(5):370-3. PubMed ID: 11778270
    [Abstract] [Full Text] [Related]

  • 19. Targeting of T lymphocytes to Neu/HER2-expressing cells using chimeric single chain Fv receptors.
    Stancovski I, Schindler DG, Waks T, Yarden Y, Sela M, Eshhar Z.
    J Immunol; 1993 Dec 01; 151(11):6577-82. PubMed ID: 7902379
    [Abstract] [Full Text] [Related]

  • 20. Identification of tumorsphere- and tumor-initiating cells in HER2/Neu-induced mammary tumors.
    Liu JC, Deng T, Lehal RS, Kim J, Zacksenhaus E.
    Cancer Res; 2007 Sep 15; 67(18):8671-81. PubMed ID: 17875707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.